# ADMA (Adma Biologics, Inc.) - SEC EDGAR Financial Statements

> Adma Biologics, Inc. reported $519.2M in revenue and net income of $182.4M for the trailing twelve months ended September 30, 2026 (up 5.1% year over year), with a 68.5% gross margin and a 46.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/ADMA
- Markdown: https://convexityos.com/fundamentals/ADMA.md
- SEC CIK: 0001368514
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:20 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001368514&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $519.2M | +5.1% YoY |
| Operating Income | TTM | $241.2M | 46.5% margin |
| Net Income | TTM | $182.4M | 35.1% net margin |
| Diluted EPS | TTM | $0.81 | Split-adjusted |
| Free Cash Flow | TTM | $132.9M | 25.6% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $124.6M | Total debt: $202.8M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $510.2M | $426.5M | $258.2M | $154.1M | $80.94M | $42.22M | $29.35M | $16.99M | $22.76M | $10.66M |
| Cost of Revenue | $217.4M | $206.9M | $169.3M | $118.8M | $79.77M | $61.29M | $39.50M | $42.19M | $29.16M | $1.61M |
| **Gross Profit** | $292.8M | $219.6M | $88.94M | $35.27M | $1.17M | -$19.07M | -$10.16M | -$25.21M | -$6.40M | $4.30M |
| Research & Development | $4.76M | $1.81M | $3.30M | $3.61M | $3.65M | $5.91M | $2.34M | $3.93M | $5.57M | $7.69M |
| Selling, General & Admin | $91.58M | $74.12M | $59.02M | $52.46M | $42.90M | $35.05M | -- | -- | -- | -- |
| Total Operating Expenses | $101.3M | $80.57M | $67.31M | $74.63M | $59.55M | $45.84M | $70.77M | $77.27M | $62.07M | $27.99M |
| **Operating Income** | $191.4M | $139.0M | $21.63M | -$39.37M | -$58.37M | -$64.91M | -$41.42M | -$60.29M | -$39.31M | -$17.33M |
| **EBITDA** | $199.4M | $146.7M | $29.23M | -$32.97M | -$53.57M | -$61.71M | -$39.02M | -$57.69M | -$37.81M | -$16.93M |
| Interest Income | $1.87M | $2.10M | $1.62M | $45K | $35K | $288K | $801K | $195K | $57K | $50K |
| Interest Expense | $7.11M | $13.93M | $25.03M | $19.28M | $13.06M | $11.99M | $8.99M | $5.52M | $3.29M | $2.24M |
| Income Before Tax | $182.7M | $125.7M | -$28.24M | -$65.90M | -- | -- | -- | -- | -- | -$19.52M |
| Income Tax Expense | $35.73M | -$71.96M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | $146.9M | $197.7M | -$28.24M | -$65.90M | -$71.65M | -$75.75M | -$48.28M | -$65.74M | -$43.76M | -$19.52M |
| Basic EPS | $0.62 | $0.85 | -$0.13 | -$0.33 | -$0.51 | -$0.88 | -$0.89 | -$1.45 | -$1.91 | -$1.61 |
| **Diluted EPS** | $0.60 | $0.81 | -$0.13 | -$0.33 | -$0.51 | -$0.88 | -$0.89 | -$1.45 | -$1.91 | -$1.61 |
| Basic Shares Outstanding | 238.3M | 233.1M | 224.0M | 197.9M | 139.6M | 86.1M | 54.3M | 45.2M | 22.9M | 12.2M |
| Diluted Shares Outstanding | 244.9M | 243.3M | 224.0M | 197.9M | 139.6M | 86.1M | 54.3M | 45.2M | 22.9M | 12.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $141.1M | $124.4M | $114.5M | $139.2M | $134.2M | $122.0M | $114.8M | $117.5M |
| Cost of Revenue | $41.19M | $38.12M | $33.74M | $50.35M | $58.60M | $54.76M | $53.70M | $54.22M |
| **Gross Profit** | $99.92M | $86.28M | $80.75M | $88.82M | $75.63M | $67.23M | $61.10M | $63.33M |
| Research & Development | $4.49M | $6.01M | $2.60M | $1.38M | $1.53M | $1.03M | $826K | $391K |
| Selling, General & Admin | $26.55M | $26.74M | $26.74M | $23.51M | $21.78M | $22.21M | $24.08M | $23.32M |
| Total Operating Expenses | $32.16M | $33.83M | $22.48M | $26.07M | $24.61M | $24.43M | $26.22M | $25.01M |
| **Operating Income** | $67.76M | $52.45M | $58.27M | $62.75M | $51.01M | $42.80M | $34.88M | $38.32M |
| **EBITDA** | $69.46M | $54.15M | $60.07M | $64.75M | $53.01M | $44.80M | $36.78M | $40.32M |
| Interest Income | -- | -- | -- | $487K | $376K | $400K | $608K | $598K |
| Interest Expense | $3.43M | $3.42M | $2.10M | $1.63M | $1.68M | $1.83M | $1.98M | $2.88M |
| Income Before Tax | $65.60M | $50.24M | $57.13M | $61.59M | $47.52M | $40.10M | $33.45M | $34.71M |
| Income Tax Expense | $15.72M | $12.41M | $11.80M | $12.22M | $11.09M | $5.88M | $6.55M | -$77.18M |
| **Net Income** | $49.88M | $37.82M | $45.33M | $49.38M | $36.43M | $34.22M | $26.90M | $111.9M |
| Basic EPS | $0.22 | $0.17 | $0.19 | -- | $0.15 | $0.14 | $0.11 | -- |
| **Diluted EPS** | $0.22 | $0.16 | $0.19 | -- | $0.15 | $0.14 | $0.11 | -- |
| Basic Shares Outstanding | 223.7M | 228.2M | 236.1M | -- | 238.6M | 241.5M | 237.8M | -- |
| Diluted Shares Outstanding | 225.8M | 230.3M | 240.0M | -- | 244.7M | 248.6M | 244.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $87.63M | $103.1M | $51.35M | $86.52M | $51.09M | $55.92M | $26.75M | $26.75M | $43.11M | $9.91M |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $5.39M |
| **Cash & Short-Term Investments** | $87.63M | $103.1M | $51.35M | $86.52M | $51.09M | $55.92M | $26.75M | $26.75M | $43.11M | $15.31M |
| Accounts Receivable, Net | $158.4M | $50.00M | $27.42M | $15.51M | $28.58M | $13.24M | $3.47M | $1.39M | $3.88M | $1.02M |
| Inventory | $206.5M | $170.2M | $172.9M | $163.3M | $124.7M | $81.54M | $53.06M | $18.62M | $12.63M | $5.02M |
| **Total Current Assets** | $466.5M | $331.4M | $257.0M | $270.4M | $208.7M | $153.7M | $85.82M | $44.53M | $62.34M | $21.66M |
| Property, Plant & Equipment, Net | $65.06M | $54.71M | $53.84M | $58.26M | $50.94M | $41.59M | $31.74M | $30.12M | $30.47M | $2.00M |
| Goodwill | $3.53M | $3.53M | $3.53M | $3.53M | $3.53M | $3.53M | $3.53M | $3.53M | $3.53M | $0 |
| Intangible Assets | $632K | $460K | $499K | $1.01M | $1.73M | $2.44M | $3.16M | $4.00M | $4.85M | $0 |
| **Total Non-Current Assets** | $157.7M | $157.3M | $72.17M | $78.06M | $67.52M | $53.93M | $41.27M | $44.35M | $45.68M | $27K |
| **Total Assets** | $624.2M | $488.7M | $329.2M | $348.5M | $276.3M | $207.7M | $127.1M | $88.88M | $108.0M | $23.69M |
| Accounts Payable | $22.52M | $20.22M | $15.66M | $13.23M | $12.43M | $11.07M | $9.17M | $5.90M | $5.92M | $2.56M |
| Short-Term Debt | $2.81M | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Current) | -- | $143K | $182K | $143K | $143K | $143K | $143K | $143K | $143K | $145K |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | -- | $58K | $17K |
| **Total Current Liabilities** | $69.54M | $55.54M | $49.81M | $39.27M | $30.38M | $19.95M | $14.03M | $9.63M | $9.44M | $11.22M |
| Long-Term Debt | $69.33M | $72.34M | -- | -- | -- | -- | $0 | $2.76M | $2.76M | $1.79M |
| Deferred Revenue (Non-Current) | $1.41M | $1.55M | $1.69M | $1.83M | $1.98M | $2.12M | $2.26M | $2.40M | $2.55M | $2.69M |
| Other Non-Current Liabilities | $0 | $360K | $419K | $350K | $397K | $55K | $107K | $261K | $106K | $118K |
| **Total Non-Current Liabilities** | $77.38M | $84.12M | $144.2M | $157.2M | $104.7M | $99.48M | $86.87M | $59.48M | $58.25M | $16.92M |
| **Total Liabilities** | $146.9M | $139.7M | $194.0M | $196.5M | $135.1M | $119.4M | $100.9M | $69.11M | $67.69M | $28.14M |
| **Total Debt (incl. Leases)** | $79.84M | $82.12M | $10.82M | $11.61M | $8.05M | $4.70M | $1.50M | $2.76M | $2.76M | $1.79M |
| Common Stock | $24K | $24K | $23K | $22K | $20K | $10K | $5.9K | $4.6K | $3.7K | $1.3K |
| Retained Earnings | -$161.7M | -$308.6M | -$506.3M | -$478.0M | -$412.1M | -$340.5M | -$264.7M | -$216.4M | -$150.7M | -$106.9M |
| **Total Stockholders' Equity** | $477.3M | $349.0M | $135.2M | $152.0M | $141.2M | $88.25M | $26.19M | $19.77M | $40.33M | -$4.46M |
| Total Equity | $477.3M | $349.0M | $135.2M | $152.0M | $141.2M | $88.25M | $26.19M | $19.77M | $40.33M | -$4.46M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $124.6M | $136.0M | $138.2M | $87.63M | $61.38M | $90.28M | $71.62M | $103.1M |
| **Cash & Short-Term Investments** | $124.6M | $136.0M | $138.2M | $87.63M | $61.38M | $90.28M | $71.62M | $103.1M |
| Accounts Receivable, Net | $169.2M | $138.2M | $135.9M | $158.4M | $137.7M | $109.7M | $99.41M | $50.00M |
| Inventory | $266.1M | $239.3M | $222.1M | $206.5M | $196.7M | $191.5M | $172.2M | $170.2M |
| **Total Current Assets** | $575.9M | $528.2M | $511.2M | $466.5M | $402.7M | $399.6M | $351.8M | $331.4M |
| Property, Plant & Equipment, Net | $66.76M | $66.66M | $65.01M | $65.06M | $69.51M | $57.50M | $57.71M | $54.71M |
| Goodwill | $3.53M | $3.53M | $3.53M | $3.53M | $3.53M | $3.53M | $3.53M | $3.53M |
| Intangible Assets | $581K | $575K | $630K | $632K | $491K | $527K | $452K | $460K |
| **Total Non-Current Assets** | $156.6M | $156.0M | $154.0M | $157.7M | $166.0M | $158.8M | $158.8M | $157.3M |
| **Total Assets** | $732.5M | $684.2M | $665.2M | $624.2M | $568.7M | $558.4M | $510.6M | $488.7M |
| Accounts Payable | $35.66M | $31.72M | $20.52M | $22.52M | $24.02M | $29.77M | $20.61M | $20.22M |
| Short-Term Debt | $4.22M | $3.75M | $3.28M | $2.81M | $2.34M | -- | -- | $0 |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | $143K | $143K | $143K |
| **Total Current Liabilities** | $95.28M | $75.76M | $73.54M | $69.54M | $56.49M | $74.94M | $53.50M | $55.54M |
| Long-Term Debt | $191.6M | $192.8M | $193.6M | $69.33M | $70.08M | -- | -- | $72.34M |
| Deferred Revenue (Non-Current) | $1.30M | $1.33M | $1.37M | $1.41M | $1.44M | $1.48M | $1.51M | $1.55M |
| Other Non-Current Liabilities | -- | -- | -- | $0 | $90K | $2.0K | $2.0K | $360K |
| **Total Non-Current Liabilities** | $198.7M | $200.2M | $201.3M | $77.38M | $81.01M | $85.11M | $83.65M | $84.12M |
| **Total Liabilities** | $294.0M | $276.0M | $274.9M | $146.9M | $137.5M | $160.1M | $137.2M | $139.7M |
| **Total Debt (incl. Leases)** | $202.8M | $203.9M | $204.4M | $79.84M | $83.12M | $10.43M | $9.49M | $82.12M |
| Common Stock | $24K | $24K | $24K | $24K | $24K | $24K | $24K | $24K |
| Retained Earnings | -$28.62M | -$78.50M | -$116.3M | -$161.7M | -$211.0M | -$247.5M | -$281.7M | -$308.6M |
| **Total Stockholders' Equity** | $438.5M | $408.2M | $390.3M | $477.3M | $431.2M | $398.3M | $373.4M | $349.0M |
| Total Equity | $438.5M | $408.2M | $390.3M | $477.3M | $431.2M | $398.3M | $373.4M | $349.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $146.9M | $197.7M | -$28.24M | -$65.90M | -$71.65M | -$75.75M | -$48.28M | -$65.74M | -$43.76M | -$19.52M |
| Depreciation & Amortization | $8.00M | $7.70M | $7.60M | $6.40M | $4.80M | $3.20M | $2.40M | $2.60M | $1.50M | $400K |
| Stock-Based Compensation | $20.03M | $13.62M | $6.19M | $5.21M | $3.49M | $2.86M | $2.65M | $2.22M | $1.56M | $1.25M |
| Change in Receivables | -$108.4M | -$22.58M | -$11.92M | $13.07M | -$15.34M | -$9.77M | $2.08M | $2.49M | -$2.86M | -$94K |
| Change in Inventory | -$36.23M | $2.67M | -$9.63M | -$38.56M | -$43.19M | -$28.47M | $34.65M | -$5.99M | $589K | -$1.57M |
| Change in Payables | $2.33M | $4.15M | $3.84M | $800K | $1.36M | $1.90M | $3.27M | -$20K | $2.81M | $477K |
| **Operating Cash Flow** | $50.40M | $118.7M | $8.80M | -$59.51M | -$112.4M | -$102.0M | -$76.19M | -$62.68M | -$37.27M | -$18.27M |
| Capital Expenditure | -$22.57M | -$8.23M | -$4.77M | -$13.91M | -$13.51M | -$12.73M | -$3.81M | -$2.10M | -$2.68M | -$73K |
| **Free Cash Flow** | $27.82M | $110.4M | $4.03M | -$73.42M | -$125.9M | -$114.7M | -$80.01M | -$64.77M | -$39.95M | -$18.34M |
| **Investing Cash Flow** | -$21.89M | -$8.57M | -$4.98M | -$13.91M | -$13.51M | -$12.72M | -$3.81M | -$2.10M | $15.21M | $905K |
| Common Stock Issued | -- | $0 | $0 | $64.64M | $121.1M | $131.2M | $48.40M | $42.94M | $39.20M | $12.90M |
| Share Repurchases | -$31.94M | $0 | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | -$44.02M | -$58.30M | -$38.99M | $108.9M | $121.0M | $143.9M | $80.00M | $42.92M | $60.75M | $16.84M |
| **Net Change in Cash** | -$15.52M | $51.80M | -$35.17M | $35.43M | -$4.83M | $29.17M | -$2.7K | -$21.85M | $38.69M | -$526K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $49.88M | $37.82M | $45.33M | $49.38M | $36.43M | $34.22M | $26.90M | $111.9M |
| Depreciation & Amortization | $1.70M | $1.70M | $1.80M | $2.00M | $2.00M | $2.00M | $1.90M | $2.00M |
| Stock-Based Compensation | $6.20M | $6.13M | $6.33M | $5.39M | $5.05M | $4.96M | $4.62M | $5.43M |
| Change in Receivables | -$30.99M | -$2.37M | $22.57M | -$20.76M | -$27.95M | -$10.31M | -$49.41M | $141K |
| Change in Inventory | -$26.80M | -$17.21M | -$15.63M | -$9.80M | -$5.20M | -$19.28M | -$1.95M | $1.57M |
| Change in Payables | $4.11M | $10.08M | -$1.23M | -$2.20M | -$4.88M | $9.27M | $142K | $3.94M |
| **Operating Cash Flow** | $17.37M | $29.54M | $58.25M | $35.64M | $13.29M | $21.14M | -$19.68M | $50.22M |
| Capital Expenditure | -$2.00M | -$2.26M | -$2.54M | -$1.08M | -$14.37M | -$2.42M | -$4.70M | -$2.76M |
| **Free Cash Flow** | $15.37M | $27.28M | $55.71M | $34.55M | -$1.07M | $18.72M | -$24.38M | $47.46M |
| **Investing Cash Flow** | -$2.07M | -$2.26M | $2.40M | -$276K | -$14.37M | -$2.53M | -$4.72M | -$2.75M |
| Share Repurchases | -$25.05M | -$25.05M | -$130.2M | -$8.90M | -$23.04M | $0 | $0 | -- |
| **Financing Cash Flow** | -$26.77M | -$29.42M | -$10.13M | -$9.12M | -$27.82M | $48K | -$7.13M | -$31.03M |
| **Net Change in Cash** | -$11.46M | -$2.13M | $50.52M | $26.25M | -$28.90M | $18.66M | -$31.52M | $16.44M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 57.4% | 51.5% | 34.4% | 22.9% | 1.4% | -45.2% | -34.6% | -148.4% | -28.1% | 40.3% |
| **Operating Margin** | 37.5% | 32.6% | 8.4% | -25.5% | -72.1% | -153.8% | -141.1% | -354.9% | -172.7% | -162.6% |
| **Net Profit Margin** | 28.8% | 46.4% | -10.9% | -42.8% | -88.5% | -179.4% | -164.5% | -387.1% | -192.3% | -183.1% |
| Return on Equity (ROE) | 30.8% | 56.6% | -20.9% | -43.4% | -50.8% | -85.8% | -184.3% | -332.5% | -108.5% | -- |
| Return on Assets (ROA) | 23.5% | 40.5% | -8.6% | -18.9% | -25.9% | -36.5% | -38.0% | -74.0% | -40.5% | -82.4% |
| Current Ratio | 6.71x | 5.97x | 5.16x | 6.89x | 6.87x | 7.71x | 6.12x | 4.63x | 6.60x | 1.93x |
| Quick Ratio | 3.74x | 2.90x | 1.69x | 2.73x | 2.77x | 3.62x | 2.34x | 2.69x | 5.27x | 1.48x |
| Debt to Equity | 0.17x | 0.24x | 0.08x | 0.08x | 0.06x | 0.05x | 0.06x | 0.14x | 0.07x | -- |
| **Revenue Growth (YoY)** | +19.6% | +65.2% | +67.6% | +90.4% | +91.7% | +43.9% | +72.8% | -25.4% | +113.5% | +48.5% |
| Gross Profit Growth (YoY) | +33.3% | +146.8% | +152.2% | +2906.4% | -- | -- | -- | -- | -248.9% | +50.0% |
| Operating Income Growth (YoY) | +37.7% | +542.5% | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -25.7% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -27.1% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -57.5% | +1248.5% | -- | -- | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -74.8% | +2641.3% | -- | -- | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | +336.8% | +238.8% | +206.7% | -21.7% | -33.9% | -28.9% | -15.2% | -20.0% | +368.2% | -59.3% |
| 10Y Revenue / Share Growth | +210.6% | +187.4% | +145.5% | +266.7% | -73.1% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 68.5% | 64.7% | 61.3% | 57.4% | 54.7% | 53.0% | 52.6% | 51.5% |
| **Operating Margin** | 46.5% | 43.8% | 42.1% | 37.5% | 34.2% | 32.8% | 33.1% | 32.6% |
| **Net Profit Margin** | 35.1% | 33.0% | 32.4% | 28.8% | 42.9% | 44.1% | 45.0% | 46.4% |
| Return on Equity (ROE) | 41.6% | 41.4% | 42.4% | 30.8% | 48.6% | 52.5% | 55.4% | 56.6% |
| Return on Assets (ROA) | 24.9% | 24.7% | 24.9% | 23.5% | 36.8% | 37.4% | 40.5% | 40.5% |
| Current Ratio | 6.04x | 6.97x | 6.95x | 6.71x | 7.13x | 5.33x | 6.58x | 5.97x |
| Quick Ratio | 3.25x | 3.81x | 3.93x | 3.74x | 3.65x | 2.78x | 3.36x | 2.90x |
| Debt to Equity | 0.46x | 0.50x | 0.52x | 0.17x | 0.19x | 0.03x | 0.03x | 0.24x |
| **Revenue Growth (YoY)** | +5.1% | +2.0% | -0.3% | +18.4% | +12.0% | +13.8% | +40.2% | +59.1% |
| Gross Profit Growth (YoY) | +32.1% | +28.3% | +32.2% | +40.2% | +26.8% | +17.0% | +56.2% | +103.7% |
| Operating Income Growth (YoY) | +32.8% | +22.5% | +67.1% | +63.7% | +28.7% | +9.2% | +59.9% | +169.3% |
| **Net Income Growth (YoY)** | +36.9% | +10.5% | +68.5% | -55.9% | +1.4% | +6.7% | +51.1% | -- |
| EPS Growth (YoY) | +46.7% | +21.4% | +72.7% | -- | 0.0% | 0.0% | +37.5% | -- |
| Operating Cash Flow Growth (YoY) | +30.7% | +39.7% | -- | -29.0% | -46.9% | -53.7% | -- | +185.4% |
| Free Cash Flow Growth (YoY) | -- | +45.8% | -- | -27.2% | -104.5% | -57.1% | -- | +189.4% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
